Bioinformatics Market Expansion Continues, with Forecast Valuation of $32.38 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Bioinformatics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The domain of bioinformatics has recently experienced swift expansion, projected to increase its valuation from $16.54 billion in 2024 to $18.54 billion by 2025, reflecting a compound annual growth rate (CAGR) totaling 12.1%; this upward trajectory throughout the historical timeframe owes its momentum to progress in genomic sequencing technologies, the acceleration of biomedical investigations, strides in pharmaceutical research and creation, the rise of customized healthcare solutions, and developments within agricultural and biotechnological fields.

Bioinformatics Market Size Forecast: What's the Projected Valuation by 2029?
The global market for bioinformatics is projected to experience a swift expansion over the coming years, reaching a valuation of $32.38 billion by the year 2029, underpinned by a compound annual growth rate (CAGR) pegged at 15.0%. This surge in expansion throughout the projection timeframe stems from several key drivers, notably the progression in omics technologies, the increasing application of artificial intelligence (AI) and machine learning, improvements in data integration and cloud computing infrastructure, advancements in identifying biomarkers and diagnostics, and enhanced interdisciplinary teamwork. Furthermore, significant trends shaping this market landscape through the forecast period encompass the voluminous growth of genomic data, the widespread adoption of personalized medicine approaches, the rising integration of machine learning and AI, and ongoing innovation in drug discovery and development processes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

What Are the Drivers Transforming the Bioinformatics Market?
Advancements within the pharmaceutical sector are projected to be a major catalyst for expansion in the bioinformatics market moving ahead. This industry, encompassing the identification, creation, and manufacturing of pharmaceuticals by both public and private organizations, heavily leverages bioinformatics to considerably speed up drug identification and development timelines, lower associated expenses, and enhance the effectiveness and security of medicinal treatments. As an illustration, data from GOV.UK, the United Kingdom's government body, showed that the UK life sciences sector achieved a turnover of 108.1 billion pounds in 2021/22, representing a 13 percent rise compared to the 95.9 billion pounds turnover reported in 2020/21 (when calibrated to 2021/22 values); consequently, the expanding pharmaceutical landscape serves to foster the expansion of the wider bioinformatics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2483&type=smp

What Long-Term Trends Will Define the Future of the Bioinformatics Market?
Leading entities within the bioinformatics sector are concentrating their efforts on engineering sophisticated technological offerings, notably bioinformatics platforms, with the aim of boosting the efficacy of data interpretation, refining the accuracy for individualized healthcare approaches, and speeding up the pace of pharmaceutical development. A bioinformatics platform constitutes a cohesive software environment or a collection of interconnected utilities engineered for the organization, processing, and comprehension of biological datasets, encompassing information from genomics, proteomics, and metabolomics, thereby aiding both investigative pursuits and clinical determinations. To illustrate this trend, during February of 2024, Metabolon, Inc., an American biotechnology firm, introduced a newly integrated bioinformatics platform; this system furnishes users with a full spectrum of analytical instruments intended to simplify metabolomics studies, allowing for the straightforward execution of demanding analytical procedures, incorporating sophisticated graphical representations such as volcano plots and principal component analysis (PCA), further enhanced by distinctive biomarker lenses that deliver focused understanding pertaining to particular biological processes and ailments.

Which Segments in the Bioinformatics Market Offer the Most Profit Potential?
The bioinformaticsmarket covered in this report is segmented -

1) By Products and Services: Knowledge Management Tools; Data Analysis Platforms; Services
2) By Application: Metabolomics; Molecular Phylogenetics; Transcriptomics; Proteomics; Chemoinformatics; Genomics; Other Applications
3) By End Users: Pharmaceutics; Animal Study; Agriculture; Forensic Science; Other End Users

Subsegments:
1) By Knowledge Management Tools: Data Integration Tools; Literature Mining Tools; Data Repositories And Databases; Biological Data Visualization Tools
2) By Data Analysis Platforms: Genomic Data Analysis Platforms; Proteomics Data Analysis Platforms; Transcriptomics Data Analysis Platforms; Metabolomics Data Analysis Platforms
3) By Services: Data Analysis Services; Consulting Services; Software And Platform-As-A-Service (PaaS); Bioinformatics Research And Development Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2483&type=smp

Which Firms Dominate the Bioinformatics Market by Market Share and Revenue in 2025?
Major companies operating in the bioinformatics market include Agilent Technologies Inc., Illumina Inc., QIAGEN NV, Affymetrix Inc., Thermo Fisher Scientific Inc., BGI Group, Dassault Systems SE, Eurofins Scientific SE, Bruker Corporation, Biomax Informatix AG, DNASTAR Inc., Partek Inc., Geneva Bioinformatics SA, Perkinelmer Inc., Accelrys Inc., Nonlinear Dynamics SA, Quest Diagnostics Inc., Sophia Genetics SA, Waters Corporation, Permin Elmer Inc., Celera Corporation, Tripos Inc., Helicos Biosciences Incorporation, IBM Life Sciences, Applied Biologicals Materials Inc., Life Technologies Corporation, GNS Healthcare Inc., DNAnexus Inc., Intrexon Bioinformatics Germany GmbH, Syapse Inc.

Which Regions Offer the Highest Growth Potential in the Bioinformatics Market?
North America was the largest region in the bioinformatics market in 2024. Western Europe was the second largest region in the bioinformatics market analysis. The regions covered in the bioinformatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2483

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.